Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 22 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

23%

5 trials in Phase 3/4

Results Transparency

0%

0 of 9 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (6)
P 1 (1)
P 2 (1)
P 3 (3)
P 4 (2)

Trial Status

Completed9
Unknown8
Recruiting2
Active Not Recruiting2
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT03976063Phase 3Active Not RecruitingPrimary

Tocolysis in the Management of Preterm Premature Rupture of Membranes Before 34 Weeks of Gestation

NCT06396078Phase 4RecruitingPrimary

Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)

NCT05353153Not ApplicableCompletedPrimary

The Psychological Experience of Pathological Pregnancy. Study of the Case of Premature Rupture of Membranes and Evaluation of the Impact of Hypnosis Support

NCT06639919RecruitingPrimary

Biochemical and Histological Changes in Pregnant Women With Preterm Premature Rupture of Membrane

NCT06443788Completed

Trans-perineal Ultrasound in Assessment of PPROMs

NCT04705935Completed

Amniochorionic Membrane Cells in the Maternal Blood as a Biomarker for Preterm Birth

NCT06074601Active Not Recruiting

MIRACLE of LIFE Study

NCT06377397Phase 3Not Yet Recruiting

Selective Antibiotics When Symptoms Develop Versus Universal Antibiotics for Preterm Neonates

NCT04294069Phase 4CompletedPrimary

Azithromycin Dose and PPROM Treatment: a Pilot Randomized Controlled Trial

NCT04516226Not ApplicableUnknownPrimary

Vaginal Cleansing With Chlorhexidine Gluconate in Women With Preterm Pre-labor Rupture of Membranes

NCT04963465UnknownPrimary

The Accuracy of Amniotic Fluid Ferning in the Second Trimester in the Diagnosis of Preterm Prelabor Rupture of Membranes

NCT01503606Phase 3CompletedPrimary

Duration of Antibiotics Treatment With Cefazolin and Clarithromycin in Women With Preterm Premature Rupture of Membrane

NCT05328817Not ApplicableUnknownPrimary

Azithromycin Versus Erythromycin For Preterm Prelabor Rupture of Membranes

NCT05207800UnknownPrimary

Predictive Value of Maternal Serum Pentraxin 3 (PTX 3) and Heparin-binding Protein (HBP) for Chorioamnionitis in Preterm Premature Rupture of Membranes

NCT04590677Unknown

Prediction of the Onset of Term and Preterm Labour

NCT04110704Not ApplicableUnknown

Cerclage After Full Dilatation Caesarean Section

NCT04807543Phase 2CompletedPrimary

Effect of Progesterone on Latent Phase Prolongation in Patients With Preterm Premature Rupture of Membranes

NCT04413019CompletedPrimary

Domiciliary Versus Hospital Management of PPROM

NCT03992534Phase 1Unknown

The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth

NCT03814278Not ApplicableCompletedPrimary

Bed Rest After Preterm Premature Rupture of the Membranes

Scroll to load more

Research Network

Activity Timeline